-
We present the case of a patient with IL-10RA mutation who developed encephalopathy after influenza infection. Genetic testing revealed a IL-10RA mutation at the 3' end of exon 4 (c.537G-->A). A cytokine study revealed elevated levels of IL-1 receptor antagonist, IL-2, IL-6, IL-8, IP-10, eotaxin, G-CSF, MCP-1, and IL-10. These findings might reflect an increased risk of severe IAE in patients with IL-10RA mutation.
-
Low-expression of CD25 on erythroblasts might correlate with anemia in myelodysplastic syndrome (MDS) patients. CD25 could be a specific marker of LSC in MDS, and could involve in the mechanisms of development and progression of MDS
-
Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation regulates IL2RA expression.
-
The AA genotype of rs2386841 in IL2RA was associated with the paucibacillary leprosy form in the start population.
-
Results are in line with the hypothesis that in the early phase of ALS, neuroprotective helper T cells infiltrate in the affected areas in the lumbar spinal cord. This was reflected in higher peripheral percentage of CD4(+) helper T cells and higher expression of FOXP3 and IL-2Ralpha.
-
a significant association was found between IL2RA SNP and susceptibility to alopecia areata in Iranian cohort
-
The gene polymorphisms at the loci of IL2RA rs2104286 and rs12722489 are closely associated with susceptibility to MS in the Chinese.
-
Higher frequency of IL2RA SNP could not be detected among multiple sclerosis patients. The difference of frequencies was statistically insignificant between groups, probably, due to low power of analysis and inadequate sample size.
-
Our meta-analysis suggests that the rs2104286 A allele is associated with increased MS risk in both Caucasians and Asians, whereas the rs12722489 C allele is associated with elevated MS risk in Caucasians but not in Asians.
-
sIL-2R could be a promising new marker for determining inflammatory disease activity in CRPS.
-
Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis.
-
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy.
-
Data show that interleukin-2 receptor alpha, tumor necrosis factor receptor 1, serum STimulation-2 (IL1RL1 gene product), and regenerating islet-derived 3-alpha were significantly associated with non-relapse mortality.
-
Our results show that the frequency of Tregs is altered in a large cohort of long-term T1D patients, a profound decrease in CD25 expression and altered IL-2 signaling are typical features of Tregs populations in long-term diabetic patients and their relatives.
-
High IL2RA expression is associated with CRLF2-rearranged acute lymphoblastic leukemia.
-
Inhibits CD25 translation through regulation of the LKB1-AMPK-mTOR pathway to suppress T cells.
-
Among patients with a low pretreatment sIL-2R level who exhibited a positive response to R-CHOP, the posttreatment sIL-2R level may help to identify those with a poor prognosis.
-
The findings not only confirm the predictive power of CD25 expression for Philadelphia chromosome translocation (Ph)+ but also demonstrate that CD25 expression is associated with RD (a biomarker correlated with prognosis) in Ph- patients. The latter finding is likely associated with underlying molecular abnormalities, including Ph-like genotype.
-
Through GWAS, we found that emotion dysregulation is associated at genome-wide level significance in a sex-specific manner, with a SNP in IL2RA in men.
-
it has been shown that CD25 serves as a negative growth regulator of Chronic myeloid leukemia leukemic stem cells.
